vs

Side-by-side financial comparison of Dexcom (DXCM) and Pentair (PNR). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Pentair). Dexcom runs the higher net margin — 21.2% vs 16.6%, a 4.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -2.9%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Pentair plc (PNR) is an American water treatment company incorporated in Ireland with tax residency in UK, with its main U.S. office in Golden Valley, Minnesota. Pentair was founded in the US, with 65% of company's revenue coming from the US and Canada as of 2017. PNR was reorganized in 2014, shifting the corporate domicile from Switzerland to Ireland.

DXCM vs PNR — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.2× larger
DXCM
$1.3B
$1.0B
PNR
Growing faster (revenue YoY)
DXCM
DXCM
+19.0% gap
DXCM
21.6%
2.6%
PNR
Higher net margin
DXCM
DXCM
4.6% more per $
DXCM
21.2%
16.6%
PNR
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-2.9%
PNR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
PNR
PNR
Revenue
$1.3B
$1.0B
Net Profit
$267.3M
$172.4M
Gross Margin
62.9%
41.8%
Operating Margin
25.6%
20.3%
Net Margin
21.2%
16.6%
Revenue YoY
21.6%
2.6%
Net Profit YoY
153.6%
11.3%
EPS (diluted)
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
PNR
PNR
Q1 26
$1.3B
$1.0B
Q4 25
$1.3B
$1.0B
Q3 25
$1.2B
$1.0B
Q2 25
$1.2B
$1.1B
Q1 25
$1.0B
$1.0B
Q4 24
$1.1B
$972.9M
Q3 24
$994.2M
$993.4M
Q2 24
$1.0B
$1.1B
Net Profit
DXCM
DXCM
PNR
PNR
Q1 26
$267.3M
$172.4M
Q4 25
$267.3M
$166.1M
Q3 25
$283.8M
$184.3M
Q2 25
$179.8M
$148.5M
Q1 25
$105.4M
$154.9M
Q4 24
$151.7M
$166.4M
Q3 24
$134.6M
$139.6M
Q2 24
$143.5M
$186.1M
Gross Margin
DXCM
DXCM
PNR
PNR
Q1 26
62.9%
41.8%
Q4 25
62.9%
40.4%
Q3 25
60.5%
41.0%
Q2 25
59.5%
40.7%
Q1 25
56.9%
39.9%
Q4 24
58.9%
38.8%
Q3 24
59.7%
39.6%
Q2 24
62.4%
39.8%
Operating Margin
DXCM
DXCM
PNR
PNR
Q1 26
25.6%
20.3%
Q4 25
25.6%
20.1%
Q3 25
20.1%
22.7%
Q2 25
18.4%
19.4%
Q1 25
12.9%
20.1%
Q4 24
17.0%
20.1%
Q3 24
15.3%
18.1%
Q2 24
15.7%
22.6%
Net Margin
DXCM
DXCM
PNR
PNR
Q1 26
21.2%
16.6%
Q4 25
21.2%
16.3%
Q3 25
23.5%
18.0%
Q2 25
15.5%
13.2%
Q1 25
10.2%
15.3%
Q4 24
13.6%
17.1%
Q3 24
13.5%
14.1%
Q2 24
14.3%
16.9%
EPS (diluted)
DXCM
DXCM
PNR
PNR
Q1 26
$0.67
Q4 25
$0.67
$1.01
Q3 25
$0.70
$1.12
Q2 25
$0.45
$0.90
Q1 25
$0.27
$0.93
Q4 24
$0.37
$0.99
Q3 24
$0.34
$0.84
Q2 24
$0.35
$1.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
PNR
PNR
Cash + ST InvestmentsLiquidity on hand
$917.7M
$67.7M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$2.7B
$3.8B
Total Assets
$6.3B
$7.1B
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
PNR
PNR
Q1 26
$917.7M
$67.7M
Q4 25
$917.7M
Q3 25
$1.8B
$128.4M
Q2 25
$1.2B
$143.0M
Q1 25
$904.9M
$140.6M
Q4 24
$606.1M
$118.7M
Q3 24
$621.2M
$218.1M
Q2 24
$939.2M
$214.3M
Total Debt
DXCM
DXCM
PNR
PNR
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.4B
Q1 25
$1.8B
Q4 24
$1.6B
Q3 24
Q2 24
$1.8B
Stockholders' Equity
DXCM
DXCM
PNR
PNR
Q1 26
$2.7B
$3.8B
Q4 25
$2.7B
$3.9B
Q3 25
$2.7B
$3.8B
Q2 25
$2.6B
$3.7B
Q1 25
$2.3B
$3.6B
Q4 24
$2.1B
$3.6B
Q3 24
$2.0B
$3.5B
Q2 24
$2.4B
$3.4B
Total Assets
DXCM
DXCM
PNR
PNR
Q1 26
$6.3B
$7.1B
Q4 25
$6.3B
$6.9B
Q3 25
$7.5B
$6.8B
Q2 25
$7.3B
$6.5B
Q1 25
$6.8B
$6.7B
Q4 24
$6.5B
$6.4B
Q3 24
$6.4B
$6.5B
Q2 24
$6.8B
$6.5B
Debt / Equity
DXCM
DXCM
PNR
PNR
Q1 26
0.51×
Q4 25
0.42×
Q3 25
0.42×
Q2 25
0.38×
Q1 25
0.51×
Q4 24
0.46×
Q3 24
Q2 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
PNR
PNR
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-85.7M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$716.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
PNR
PNR
Q1 26
Q4 25
$294.0M
$50.8M
Q3 25
$659.9M
$196.3M
Q2 25
$303.0M
$606.6M
Q1 25
$183.8M
$-38.9M
Q4 24
$301.4M
$86.5M
Q3 24
$199.5M
$248.6M
Q2 24
$279.4M
$539.2M
Free Cash Flow
DXCM
DXCM
PNR
PNR
Q1 26
$-85.7M
Q4 25
$192.1M
$27.1M
Q3 25
$579.4M
$178.9M
Q2 25
$208.9M
$595.7M
Q1 25
$96.8M
$-55.7M
Q4 24
$176.8M
$63.8M
Q3 24
$88.3M
$233.2M
Q2 24
$213.3M
$522.2M
FCF Margin
DXCM
DXCM
PNR
PNR
Q1 26
-8.3%
Q4 25
15.3%
2.7%
Q3 25
47.9%
17.5%
Q2 25
18.1%
53.0%
Q1 25
9.3%
-5.5%
Q4 24
15.9%
6.6%
Q3 24
8.9%
23.5%
Q2 24
21.2%
47.5%
Capex Intensity
DXCM
DXCM
PNR
PNR
Q1 26
1.8%
Q4 25
8.1%
2.3%
Q3 25
6.7%
1.7%
Q2 25
8.1%
1.0%
Q1 25
8.4%
1.7%
Q4 24
11.2%
2.3%
Q3 24
11.2%
1.6%
Q2 24
6.6%
1.5%
Cash Conversion
DXCM
DXCM
PNR
PNR
Q1 26
Q4 25
1.10×
0.31×
Q3 25
2.33×
1.07×
Q2 25
1.69×
4.08×
Q1 25
1.74×
-0.25×
Q4 24
1.99×
0.52×
Q3 24
1.48×
1.78×
Q2 24
1.95×
2.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

PNR
PNR

Water Solutions$391.0M38%
Pool$387.1M37%
Flow$258.1M25%

Related Comparisons